(Q40506489)

21 September 2017

1 reference

title

The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients (English)

1 reference

21 September 2017

1 reference

Front D

1

1 reference

21 September 2017

Israel O

series ordinal

2

1 reference

21 September 2017

language of work or name

1 reference

1 January 1995

1 reference

Seminars in Nuclear Medicine

21 September 2017

published in

1 reference

21 September 2017

volume

25

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

60-71

1 reference

Gallium 67 imaging in monitoring lymphoma response to treatment

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Ga-67 SPECT before and after treatment of lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Lymphoma: predictive value of Ga-67 scintigraphy after treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Role of the gallium scan in Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

High-dose gallium imaging in lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Lymphoma: evaluation with Ga-67 SPECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Normal and abnormal Ga-67 SPECT anatomy in patients with lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Results of MIME salvage regimen for recurrent or refractory lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Mediastinal Hodgkin disease in children: response to therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Residual mass in lymphoma may not be residual disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Characterization of lymphadenopathy by magnetic resonance relaxation times: preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Non-Hodgkin lymphoma: predicting prognostic grade with MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Lymphoma: monitoring tumor size and signal intensity with MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

The role of gallium-67 in the clinical evaluation of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

When is a prognostic factor useful? A guide for the perplexed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980007-8

10.1016/S0001-2998(05)80007-8

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference